Webinar: Patient-Derived Xenografts as Models for Metastatic Breast Cancer and Preclinical Therapy Testing

English
简体
繁體中文
日本語

General Contact

TECHNICAL SUPPORT
+1.800.674.3430
This line is for technical support.
For General Enquiries please click General Contact

About
CVMD
Oncology
Inflammation
- Menu Column 1
  - In Vivo Models
    - Inflammatory Bowel Disease (IBD)
    - Rheumatoid Arthritis (RA)
- Menu Column 2
  - Biomarker Assay Services

Models
Resources
Blog
Databases
- OncoExpress
- HuBase
- OrganoidBase
- XenoBase
- MuBase

Site Search 360
Call
Email

About
CMVD
Oncology
Inflammation
- In Vivo Models
  - Inflammatory Bowel Disease
  - Rheumatoid Arthritis (RA)
- Biomarker Servicers
Models
Resources
Blog
Databases
- OncoExpress
- HuBase
- OrganoidBase
- XenoBase
- MuBase
Contact

x

Upcoming Event

Posters
Events

"CrownBio brings clarity to drug discovery around the world by helping biopharmaceutical companies solve some of today's most pressing problems in oncology, cardiovascular, and metabolic disease.

Leveraging our industry expertise, CrownBio's global resources help customers answer the most challenging questions about human biology. We begin with the end insight to help you achieve your goals"

Dr Jean-Pierre Wery
CEO, Crown Bioscience Inc.

Webinar: Patient-Derived Xenografts as Models for Metastatic Breast Cancer and Preclinical Therapy Testing

Event Date: September 27 - 28, 2018

Event Location:

Corporate

About Us
Careers
Investors - Investor relations
Leadership Team
About JSR Life Sciences
Scientific Advisors
Strategic Partners
Vision & Mission
What we do
News
Resources
Blog

Models

Cell Line Derived Xenograft
HSC and PBMC Humanized
Human Target Knock-In ( HuGEMM^TM )
Patient-Derived Xenograft ( HuPrime^TM )
Syngeneic
Tumor Homograft ( MuPrime^TM )

Inflammation

In Vivo Models

Inflammatory Bowel Disease (IBD)
Rheumatoid Arthritis (RA)

Biomarker Services

Flow Cytometry Platform
Histology and Digital Pathology Platform

CVMD

Home

Cardiovascular Disease

NHP
Rodent

NHP
Rodent

NHP
MS-NASH (FATZO)

NHP
Rodent

Renal Disease

NHP
Rodent

Safety/Toxicology

Non-GLP Toxicology
Safety Pharmacology

Oncology

In Vivo Services

Breast Cancer Preclinical Models
Cell Line Derived Xenograft Models
Custom Tumor Model Development
Immuno-Oncology Model
MuScreen
Orthotopic and Bioluminescent Models
Patient-Derived Xenograft Models (HuPrime/HuKemia)
Prostate Cancer Preclinical Model
Radiation Therapy
Syngeneic Tumor Models

In Vitro Services

Cell Based Screening
- CrownSyn
Cell Line Panels
Flow Cytometry Platform
Immuno-Oncology
OmniScreen Cell Based Screening Service
Organoids
PDX-Derived Cell Lines

Ex Vivo Services

3D Assays
Tumor Microarrays

Immuno-Oncology

CAR-T Cell Therapy Models
Humanized Models
- Hematopoietic Stem Cell (HSC)-PDX
- MiXeno
Human Target Knock-In Models
- HuGEMM
- HuCELL
Murine Immunity Model and Services

Oncology

Translational Oncology

Biomarkers of Response (HuMark)
Mouse Clinical Trials (HuTrial)
Signatures of Response (HuSignature)

Biomarker Assay Services

Cytokine and Chemokine Profiling
Flow Cytometry
Histology and Digital Pathology
Rare Cell Analysis

Bioinformatics

CrownSyn

Pharmacology and Bioanalytical Services

ADME & Physicochem
Bioanalysis Studies
FACS Platform
In Vivo PK/PD
NHP Immuno-Safety
Structural Biology
Target Validation

Oncology Databases

HuBase
OrganoidBase
MuBase
OncoExpress
XenoBase

Follow Us

© 2019 Crown Bioscience Inc.

Contact Us
Site Map
Terms of Use
Ordering Terms
Privacy Policy

© 2019 Crown Bioscience Inc.